BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 26, 2005
View Archived Issues
Rigel, Serono Enter $160M Aurora Kinase Inhibitor Deal
A preclinical program focused on Aurora kinase inhibitors brought Rigel Pharmaceuticals Inc. its fifth oncology deal, this one signed with Serono SA and worth up to $160 million. (BioWorld Today)
Read More
Marinus' Series A Nets $29M To Build CNS Drug Pipeline
Read More
Flu Vaccines Now Urged For All Americans Going Forward
Read More
Allon Building Pipeline Of Neuroprotective Products
Read More
Other News To Note
Read More
Appointments And Advancements
Read More